Form 8-K - Current report:
SEC Accession No. 0001104659-25-037137
Filing Date
2025-04-22
Accepted
2025-04-22 07:30:31
Documents
13
Period of Report
2025-04-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2512826d1_8k.htm   iXBRL 8-K 24812
  Complete submission text file 0001104659-25-037137.txt   197140

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA lqda-20250421.xsd EX-101.SCH 3014
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE lqda-20250421_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lqda-20250421_pre.xml EX-101.PRE 22358
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2512826d1_8k_htm.xml XML 3652
Mailing Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560
Business Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560 919.328.4400
Liquidia Corp (Filer) CIK: 0001819576 (see all company filings)

EIN.: 851710962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39724 | Film No.: 25854971
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)